← Evidence map

ArticleJRSM open2025

Therapeutic value of oncology products with a conditional approval from Health Canada: a cross-sectional study.

Joel LexchinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40124210